全文获取类型
收费全文 | 135838篇 |
免费 | 10257篇 |
国内免费 | 237篇 |
专业分类
耳鼻咽喉 | 1262篇 |
儿科学 | 3825篇 |
妇产科学 | 2821篇 |
基础医学 | 21295篇 |
口腔科学 | 3528篇 |
临床医学 | 11604篇 |
内科学 | 27520篇 |
皮肤病学 | 2316篇 |
神经病学 | 13298篇 |
特种医学 | 5623篇 |
外国民族医学 | 16篇 |
外科学 | 16967篇 |
综合类 | 634篇 |
现状与发展 | 1篇 |
一般理论 | 108篇 |
预防医学 | 15282篇 |
眼科学 | 2186篇 |
药学 | 8213篇 |
中国医学 | 253篇 |
肿瘤学 | 9580篇 |
出版年
2023年 | 539篇 |
2022年 | 716篇 |
2021年 | 2095篇 |
2020年 | 1533篇 |
2019年 | 2214篇 |
2018年 | 2799篇 |
2017年 | 2385篇 |
2016年 | 2573篇 |
2015年 | 2895篇 |
2014年 | 3912篇 |
2013年 | 5195篇 |
2012年 | 7913篇 |
2011年 | 7933篇 |
2010年 | 4155篇 |
2009年 | 4369篇 |
2008年 | 7074篇 |
2007年 | 7248篇 |
2006年 | 7035篇 |
2005年 | 6660篇 |
2004年 | 5676篇 |
2003年 | 5400篇 |
2002年 | 4907篇 |
2001年 | 4763篇 |
2000年 | 4743篇 |
1999年 | 4218篇 |
1998年 | 1783篇 |
1997年 | 1469篇 |
1996年 | 1545篇 |
1995年 | 1279篇 |
1994年 | 1190篇 |
1993年 | 1090篇 |
1992年 | 2908篇 |
1991年 | 2619篇 |
1990年 | 2501篇 |
1989年 | 2344篇 |
1988年 | 2136篇 |
1987年 | 1903篇 |
1986年 | 1820篇 |
1985年 | 1723篇 |
1984年 | 1237篇 |
1983年 | 1090篇 |
1982年 | 595篇 |
1981年 | 538篇 |
1980年 | 450篇 |
1979年 | 958篇 |
1978年 | 586篇 |
1977年 | 493篇 |
1974年 | 495篇 |
1973年 | 477篇 |
1972年 | 430篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Can EGFR mutation status be reliably determined in pre‐operative needle biopsies from adenocarcinomas of the lung?
下载免费PDF全文
![点击此处可从《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kim Hein Lindahl Flemming Brandt Sørensen Søren Peter Jonstrup Karen Ege Olsen Siegfried Loeschke 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(4):289-297
The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis. 相似文献
13.
Maaike van Gerwen MD Naomi Alpert MS Raja Flores MD Emanuela Taioli MD PhD 《American journal of industrial medicine》2020,63(2):115-120
The association between asbestos exposure, mainly in occupational settings, and malignant mesothelioma has been well established; this has prompted several countries to establish mesothelioma epidemiologic surveillance programs often at the request of national agencies. This review compares currently existing mesothelioma registries worldwide to develop a concept model for a US real-time case capture mesothelioma registry. Five countries were identified with a mesothelioma specific registry, including Italy, France, UK, Australia, and South Korea. All, except the UK, used interviews to collect exposure data. Linkage with the national death index was available or was in future plans for all registries. The registries have limited information on treatment, quality of life, and other patient-centered outcomes such as symptoms and pain management. To thoroughly collect exposure data, “real-time” enrollment is preferable; to maximize the capture of mesothelioma cases, optimal coverage, and a simplified consent process are needed. 相似文献
14.
15.
16.
17.
18.
19.
20.
Ragnhild B. Wijma Marloes Emous Merel van den Broek Anke Laskewitz Anneke C. Muller Kobold André P. van Beek 《Surgery for obesity and related diseases》2019,15(1):73-81